What is the Impact Factor of Cytotherapy?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Cytotherapy is 4.50, ranking in quartile Q2 of Web of Science (SCIE).

Is Cytotherapy indexed in Web of Science or Scopus?

Yes, Cytotherapy is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 1.249 (Q1) and an H-index of 115.

Who publishes Cytotherapy and what is the Article Processing Charge (APC)?

Cytotherapy is published by Elsevier Inc.. The estimated Article Processing Charge (APC) is approximately $3,392 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Cytotherapy?

The official ISO-4 abbreviation of Cytotherapy is "CYTOTHERAPY" with common acronym "jcyt". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q1SCImago #3,388Hybrid

Cytotherapy

Acronym:jcyt

•

Abbreviation (ISO):CYTOTHERAPY

•

Identifier (ISSN):1465-3249(Print)/1477-2566(Online)

•

Publisher:Elsevier Inc.

Official Website Submission Portal Compare

Clarivate IF (2026)

4.5↑ +1.3

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIEJCR Quartile

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Cytotherapy

WoS Q2

Annual Impact Factor Metric

Current (2026):4.5

Scopus SJR & RankScopus Q1

1.249

#3,388

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

115

115 papers with at least that number of citations each

WoS: SCIE / JCRQ2

Self-Citation Rate8.1%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

126articles/year

33.33% Gold OA•81.42% Original Research

Aims & Scope

The journal brings readers the latest developments in the fast moving field of cellular therapy in man. This includes cell therapy for cancer, immune disorders, inherited diseases, tissue repair and regenerative medicine. The journal covers the science, translational development and treatment with variety of cell types including hematopoietic stem cells, immune cells (dendritic cells, NK, cells, T cells, antigen presenting cells) mesenchymal stromal cells, adipose cells, nerve, muscle, vascular and endothelial cells, and induced pluripotential stem cells. We also welcome manuscripts on subcellular derivatives such as exosomes. A specific focus is on translational research that brings cell therapy to the clinic. Cytotherapy publishes original papers, reviews, position papers editorials, commentaries and letters to the editor. We welcome "Protocols in Cytotherapy" bringing standard operating procedure for production specific cell types for clinical use within the reach of the readership.

Topics Covered (Recognized by AI)

Biology86.1%Medicine81.5%Genetics78.9%Chemistry64.7%Internal medicine61.6%Cell biology60%Biochemistry58.6%Immunology51.5%Pathology48.9%Stem cell38.1%Cancer research31.6%Mesenchymal stem cell29.5%In vitro28.6%Gene23%Surgery22.7%Cell22.4%

Primary Research Areas

Rank65/191

IndexSCIE

Category	Index	Rank	Quartile
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCRSCIE	57/180	Q2
CELL & TISSUE ENGINEERING	JCRSCIE	14/32	Q2
CELL BIOLOGY	JCRSCIE	91/207	Q2
HEMATOLOGY	JCRSCIE	22/103	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCRSCIE	59/191	Q2
BIOTECHNOLOGY & APPLIED MICROBIOLOGY	JCISCIE	63/180	Q2
CELL & TISSUE ENGINEERING	JCISCIE	11/32	Q2
CELL BIOLOGY	JCISCIE	78/207	Q2
HEMATOLOGY	JCISCIE	25/103	Q1
MEDICINE, RESEARCH & EXPERIMENTAL	JCISCIE	65/191	Q2

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF4.5

Articles / Year792

Total Citations49

2025

IF3.2

Articles / Year755

Total Citations748

2024

IF3.7

Articles / Year780

Total Citations1,753

2023

IF4.5

Articles / Year783

Total Citations1,879

2022

IF6.196

Articles / Year663

Total Citations2,049

Year	Impact Factor	Articles / Year	Total Citations
2026	4.5	792	49
2025	3.2	755	748
2024	3.7	780	1,753
2023	4.5	783	1,879
2022	6.196	663	2,049
2021	5.414	656	2,431
2020	4.218	661	3,787
2019	4.297	445	4,014
2018	3.993	564	5,146
2017	—	594	5,444
2016	—	477	6,802
2015	—	513	6,826

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #3,388Scopus Q1SCImago Profile

Scopus Coverage:1999-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyMedicine

Scopus Citation Rank (SJR)Q1

1.249

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q1

Citations / Doc (2 years)

4.15

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,392 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations1,748

3-Year Documents449

Citable Documents433

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate44.9%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Genetics (clinical)Q1

OncologyQ1

TransplantationQ1

Cancer ResearchQ2

Cell BiologyQ2

ImmunologyQ2

Immunology and AllergyQ2

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 8.1%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

3区 (Zone 3)Medicine

Minor Category (Specific Field):

3区CELL & TISSUE ENGINEERING

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Cytotherapy (acronym: jcyt, abbr: CYTOTHERAPY, ISSN: 1465-3249) is a peer-reviewed international scholarly journal in the field of Medicine, published by Elsevier Inc. in Norway since 1999. The periodical holds a Journal Impact Factor (JIF) of 4.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 1.249 (Q1), an H-index of 115.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 126 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,392 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.